News
Hayao Miyazaki and Makoto Shinkai master writing balanced men and women, offering a blueprint for richer, more realistic ...
Blueprint Medicines soared by 26.09 percent on Monday to close at $127.79 each following news that it is set to be acquired by French pharmaceutical giant Sanofi for $9.1 billion.
French pharmaceuticals giant Sanofi has agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the company aims to expand the company's reach in rare immunological diseases, reported ...
Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...
Sanofi to acquire Blueprint Medicines for up to $9.5B to expand its rare immunological disease portfolio, including an FDA-approved treatment.
Sanofi plans to buy Blueprint Medicines in a deal worth more than $9 billion, expanding its immunology pipeline ...
Esports News: Call of Duty: Black Ops 6 and Warzone players can unlock free weapon blueprints by pre-ordering, participating in beta testing, or linking their accou ...
Nvidia today announced a significant expansion of the Nvidia Omniverse Blueprint for AI factory digital twins, now available as a preview.
In Demon Slayer, Nezuko's newfound sunlight immunity sends shockwaves through the demon world, making her Muzan Kibutsuji's prime target. Muzan, despe ...
Blueprint is in a lurch after major public outcry stopped the intergovernmental agency's plans to revamp Thomasville Road and adjoining sidewalks in Midtown Tallahassee. Hoping to piggyback on the ...
OpenAI has published a 'blueprint' for AI economic development and regulation in the U.S. that it argues would ensure the U.S.' technological dominance.
Blueprint will halt a clinical-stage CDK2 inhibitor even as the Ayvakit-maker pushes forward with similar preclinical breast cancer therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results